BioArctic AB (publ)

OTCPK:BRCT.F Stock Report

Market Cap: US$3.1b

BioArctic Management

Management criteria checks 3/4

BioArctic's CEO is Gunilla Osswald, appointed in Jan 2014, has a tenure of 12.67 years. total yearly compensation is SEK13.52M, comprised of 36.7% salary and 63.3% bonuses, including company stock and options. directly owns 0.081% of the company’s shares, worth $2.48M. The average tenure of the management team and the board of directors is 5.5 years and 6.8 years respectively.

Key information

Gunilla Osswald

Chief executive officer

SEK 13.5m

Total compensation

CEO salary percentage36.73%
CEO tenure12.7yrs
CEO ownership0.08%
Management average tenure5.5yrs
Board average tenure6.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Gunilla Osswald's remuneration changed compared to BioArctic's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026n/an/a

SEK 106m

Mar 31 2026n/an/a

SEK 213m

Dec 31 2025SEK 14mSEK 5m

SEK 1b

Sep 30 2025n/an/a

SEK 1b

Jun 30 2025n/an/a

SEK 1b

Mar 31 2025n/an/a

SEK 902m

Dec 31 2024SEK 10mSEK 5m

-SEK 177m

Sep 30 2024n/an/a

-SEK 233m

Jun 30 2024n/an/a

-SEK 88m

Mar 31 2024n/an/a

-SEK 122m

Dec 31 2023SEK 22mSEK 4m

SEK 229m

Sep 30 2023n/an/a

SEK 259m

Jun 30 2023n/an/a

SEK 270m

Mar 31 2023n/an/a

SEK 327m

Dec 31 2022SEK 9mSEK 5m

-SEK 11m

Sep 30 2022n/an/a

SEK 28m

Jun 30 2022n/an/a

-SEK 147m

Mar 31 2022n/an/a

-SEK 135m

Dec 31 2021SEK 5mSEK 3m

-SEK 120m

Sep 30 2021n/an/a

-SEK 114m

Jun 30 2021n/an/a

-SEK 97m

Mar 31 2021n/an/a

-SEK 101m

Dec 31 2020SEK 5mSEK 3m

-SEK 69m

Sep 30 2020n/an/a

-SEK 72m

Jun 30 2020n/an/a

-SEK 60m

Mar 31 2020n/an/a

SEK 78m

Dec 31 2019SEK 7mSEK 3m

SEK 88m

Compensation vs Market: Gunilla's total compensation ($USD1.41M) is below average for companies of similar size in the US market ($USD6.99M).

Compensation vs Earnings: Gunilla's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Gunilla Osswald (65 yo)

12.7yrs
Tenure
SEK 13,522,000
Compensation

Dr. Gunilla Osswald, Ph D., has been the Chief Executive Officer and President of BioArctic AB (publ) since 2014. Dr. Osswald has been a Director of Egetis Therapeutics AB (publ) (formerly known as PledPha...

Leadership Team

NamePositionTenureCompensationOwnership
Gunilla Osswald
President & CEO12.7yrsSEK 13.52m0.081%
$ 2.5m
Pär Gellerfors
Co-Founder & Senior VP of Business Strategy23.7yrsSEK 336.00kno data
Lars Lannfelt
Co-Founder23.7yrsSEK 2.86m31.93%
$ 974.9m
Anders Martin-Lof
Secretary of the Board & CFO3.3yrsno data0.0028%
$ 86.1k
Per-Ola Freskgard
Chief Scientific Officerno datano datano data
Oskar Bosson
VP and Head of IR & Communication6.3yrsno data0.0081%
$ 248.2k
Emilie Smith
General Counsel and Head of Legal & IPno datano data0.000010%
$ 305.3
Harald Borgeke
Head of Public Affairs4.4yrsno datano data
Frida Lekander
Head of Marketing4.6yrsno datano data
Rebecca Kastell
VP & Head of HR1.6yrsno datano data
Johanna Fälting
Chief R&D Officer and Head of Research & Developmentno datano data0.024%
$ 717.8k
Mikael Moge
VP & Head of CMCno datano data0.013%
$ 411.8k
5.5yrs
Average Tenure
55yo
Average Age

Experienced Management: BRCT.F's management team is seasoned and experienced (5.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lars Lannfelt
Co-Founder23.7yrsSEK 2.86m31.93%
$ 974.9m
Eugen Steiner
Independent Chairman9yrsSEK 858.00k0.10%
$ 3.1m
Hans Wigzell
Member of Scientific Advisory Boardno datano datano data
Konrad Beyreuther
Member of the Scientific Boardno datano datano data
Marie Edstrom
Independent Director3.3yrsSEK 402.00k0.0073%
$ 223.8k
Mikael Smedeby
Independent Director8.3yrsSEK 359.00k0.0050%
$ 152.0k
Charlotta Ljungqvist
Independent Director5.3yrsSEK 362.00k0.0036%
$ 108.7k
Martin Ingelsson
Member of Scientific Boardno datano datano data
Staffan Pauli
Member of Scientific Advisory Boardno datano datano data
Ken Marek
Member of Scientific Advisory Boardno datano datano data
Kaj Blennow
Member of Scientific Advisory Boardno datano datano data
Anna-Lena Engwall
Independent Director2.7yrsSEK 359.00k0.00089%
$ 27.2k
6.8yrs
Average Tenure
65yo
Average Age

Experienced Board: BRCT.F's board of directors are considered experienced (6.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 00:24
End of Day Share Price 2026/09/03 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioArctic AB (publ) is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonDNB Carnegie
Rajan SharmaGoldman Sachs
Viktor SundbergNordea Markets